Medicine
3 years ago

Antibody Combo Halts COVID-19 Progression, Offering Hope for Vulnerable Populations

JAMA
Realizing the Potential of Anti–SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management
Jonathan Z. Li, Rajesh T. Gandhi

Paper Summary

The combination of Casirivimab and Imdevimab can help reduce the development of symptoms in people infected with the SARS-CoV-2 virus, which causes COVID-19.

Related papers

Theme background image
Medicine
2 years ago

Millions Suffer Debilitating Long-Term Effects from COVID-19 Infection

Neurological COVID-19
Fibromyalgia Syndrome
Interoception
Theme background image
Medicine
4 years ago

COVID-19 Patients' Peritoneal Fluid Contains SARS-CoV-2, Study Finds

Cancer COVID-19
COVID-19
Appendicitis Management
Theme background image
Mathematics
5 years ago

No SARS-CoV-2 Found Among Plenty of Coronaviruses: Study

COVID-19 Modeling
COVID-19
Deep Learning